The absorbable tissue spacer market is estimated at USD 542.0 million in 2026, is projected to reach USD 1,027.0 million by 2036 and is forecast to register a 6.6% CAGR between 2026 and 2036. In 2026, hydrogel-based spacers hold 70.2% of technology sales and hospitals represent 69.0% within the end user segment.